NCT00960180

Study Evaluating Single Ascending Doses of MR1817

A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Single Doses of Orally Administered MR1817 in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: Mochida Pharmaceutical Company, Ltd. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a first-in-human study of MR1817. This study will provide an initial assessment of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of MR1817 after administration of ascending single oral doses to healthy adult subjects.

Conditions

• Adult

Interventions

Type	Name	Description
DRUG	MR1817
DRUG	Placebo

Timeline

• Start date: 2010-07-01
• Primary completion: 2011-01-01
• Completion: 2011-01-01
• First posted: 2009-08-17
• Last updated: 2014-01-13

Locations

1 site across 1 country: United Kingdom